The argument of the ORBITA study: angioplasty is useless

L Bolognese - European Heart Journal Supplements, 2020 - academic.oup.com
The goal of treatment in stable coronary artery disease is to improve prognosis and quality of
life of the patients. International Guidelines support revascularization procedures for …

[HTML][HTML] The ORBITA trial: A point of view

VD Oliveira, FR Giugni, EB Martins… - Revista da Associação …, 2018 - SciELO Brasil
Treatment of stable coronary artery disease (CAD) relies on improved prognosis and relief of
symptoms. National and international guidelines on CAD support the indication for …

Rethinking revascularization in patients with stable angina

RE Harskamp, DW Park - Expert Review of Cardiovascular …, 2018 - Taylor & Francis
Introduction: Traditional and current perception for benefit of percutaneous coronary
intervention (PCI) is that patients with stable angina will obtain symptom relief as well as …

[PDF][PDF] Debate.“Orbiting” around the management of stable angina. The interventional cardiologist's perspective

JM Moreiras - recintervcardiol.org
Answer: The 2 ORBITA studies aim to settle the debate on the utility of coronary
revascularization in patients with stable chronic angina and coronary artery lesions causing …

[HTML][HTML] Publish in our journal

D Vivas - recintervcardiol.org
ANSWER: The 2 ORBITA studies aim to settle the debate on the utility of coronary
revascularization in patients with stable chronic angina and coronary artery lesions causing …

Quality of life assessment in trials of revascularization for chronic stable angina: insights from ORBITA and the implications of blinding

AN Nowbar, DP Francis, RK Al-Lamee - Cardiovascular drugs and therapy, 2022 - Springer
The main aims of therapy in chronic stable angina are to reduce the risk of myocardial
infarction and death and improve symptoms and quality of life (QoL). Unblinded trials have …

ORBITA revisited: what it really means and what it does not?

BR Chaitman, M Mori Brooks, K Fox… - European Heart …, 2018 - academic.oup.com
Ever since William Heberden's seminal description of angina pectoris in 1772, 1 attempts
have been made to find an effective treatment of this condition. Thomas Lauder Brunton was …

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial

R Al-Lamee, D Thompson, HM Dehbi, S Sen, K Tang… - The Lancet, 2018 - thelancet.com
Background Symptomatic relief is the primary goal of percutaneous coronary intervention
(PCI) in stable angina and is commonly observed clinically. However, there is no evidence …

ORBITA: What It Means for Coronary Stenting in Stable Coronary Artery Disease

DP Francis - Health Affairs Forefront, 2018 - healthaffairs.org
Editor's note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A
Landmark Trial," which focuses on the recent study finding that coronary stenting did not …

Protocol 15PRT/06897: objective randomised blinded investigation with optimal medical therapy of angioplasty in stable angina (ORBITA trial)‐NCT02062593 …

DP Francis, JE Davies, R Al-Lamee, S Thom… - Lancet, 2016 - thelancet.com
Background Percutaneous coronary intervention (PCI) is commonly used to relieve
symptoms in chronic stable angina. However, there has no been no study of PCI against a …